Yajing Lyu
Impact in
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism
- Cancer-related molecular mechanisms research
-
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Cancer, Hypoxia, and Metabolism 9
- Cancer-related molecular mechanisms research 2
-
- RNA modifications and cancer 3
- Angiogenesis and VEGF in Cancer 1
- Epigenetics and DNA Methylation 1
- Extracellular vesicles in disease 1
- Co-authors
- Gregg L. Semenza (10 shared papers)Yongkang Yang (10 shared papers)Haiquan Lu (6 shared papers)Shaima Salman (8 shared papers)Yayun Zhu (3 shared papers)Robert N. Cole (1 shared paper)Yufeng Wang (4 shared papers)Emmanuel Datan (5 shared papers)
- Journals
- Cell Reports (3 papers)Science Advances (3 papers)Nature Communications (1 paper)Proceedings of the National Academy of Sciences (1 paper)Journal of Clinical Investigation (1 paper)
- Partner nations
- United StatesChinaFrance
In The Last Decade
Yajing Lyu
10 papers receiving 354 citations
Peers
Comparison fields: 5 of 53
- Cancer Research 161
- Oncology 89
- Immunology 66
- Molecular Biology 181
- Biotechnology 15
Countries citing papers authored by Yajing Lyu
This map shows the geographic impact of Yajing Lyu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yajing Lyu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yajing Lyu more than expected).
Fields of papers citing papers by Yajing Lyu
This network shows the impact of papers produced by Yajing Lyu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yajing Lyu. The network helps show where Yajing Lyu may publish in the future.
Co-authors
The 25 scholars most cited alongside Yajing Lyu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 70 | |
| 2 | 2021 | 68 | |
| 3 | HIF inhibitor 32-134D eradicates murine hepatocellular carcinoma in combination with anti-PD1 therapy | 2022 | 67 |
| 4 | 2021 | 65 | |
| 5 | 2021 | 38 | |
| 6 | 2022 | 22 | |
| 7 | 2023 | 12 | |
| 8 | 2024 | 9 | |
| 9 | 2024 | 3 | |
| 10 | 2025 | 2 |
About Yajing Lyu
Yajing Lyu is a scholar working on Cancer Research, Molecular Biology, Oncology, Physiology and Immunology, having authored 10 papers that have together received 356 indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (9 papers), RNA modifications and cancer (3 papers), Cancer-related molecular mechanisms research (2 papers), Adipose Tissue and Metabolism (2 papers), Hepatocellular Carcinoma Treatment and Prognosis (1 paper), Angiogenesis and VEGF in Cancer (1 paper), Epigenetics and DNA Methylation (1 paper) and Extracellular vesicles in disease (1 paper). The work is most often cited by research in Cancer Research (161 citations), Oncology (89 citations), Immunology (66 citations), Molecular Biology (181 citations) and Biotechnology (15 citations). Yajing Lyu has collaborated with scholars based in United States, China and France. Frequent co-authors include Gregg L. Semenza, Yongkang Yang, Haiquan Lu, Shaima Salman, Yayun Zhu, Robert N. Cole, Yufeng Wang, Emmanuel Datan, Elizabeth E. Wicks and Qiaozhu Zuo. Their work appears in journals such as Cell Reports, Science Advances, Nature Communications, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.